LGM Pharma invests $6 M in U.S. drug manufacturing capabilities for liquids, suspensions, semi-solids, and suppositories

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing facility as part of its Phase I CDMO growth strategy.

The Biggest Psychedelic News This Week: December 11 – 15

While everyone was preparing to head to Wonderland Miami, the psychedelic space saw a week full of debates! From the FDA’s recommendation to limit psychological

December 15, 2023

FDA approves label expansion for Novartis’ Leqvio – Pharmaceutical Technology

Leqvio is priced at around $6,500 a year, which is comparable to its competitors Sanofi/Regeneron’s Repatha (evolocumab) and Amgen’s Praluent (alirocumab). Image Credit: SurfsUp /

July 10, 2023

Diagnostic Errors Common in Hospital Deaths, ICU Transfers, Study Suggests

Diagnostic errors among hospitalized adults who died or were transferred to the intensive care unit (ICU) were fairly common, a retrospective cohort study suggested. In

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.